Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1993
06/24/1993CA2122585A1 Transdermal azidothymidine
06/24/1993CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same
06/23/1993EP0547689A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope
06/23/1993EP0547646A2 Crystalline form of a cephalosporin antibiotic
06/23/1993EP0547484A1 Process for producing antibiotic R106-I
06/23/1993EP0547446A2 Vaccines based on modified bovine herpesvirus type I
06/23/1993EP0547294A1 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
06/23/1993EP0547149A1 Inhibition of herpesviridae infection by antisense oligonucleotides
06/23/1993EP0547145A1 Antiviral 2(1h)-quinolinone compounds
06/23/1993EP0249635B1 Word recognition in a speech recognition system using data reduced word templates
06/23/1993CN1073444A Cephalosporin compounds and process for preparing the same
06/23/1993CN1073442A Method for preparing 3S,4R-N-oxalyl-3-ethyl-4-|1R-oxo-3S-thiolanylthio (thiocarbonyl)-thio¨-2-azetidinones
06/23/1993CN1021328C Process for preparing pyridazinamine derivatives
06/22/1993US5221741 Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride
06/22/1993US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents
06/22/1993CA1319324C Therapeutical compositions against psoriasis
06/22/1993CA1319321C Pharmaceutical preparations
06/21/1993CA2085834A1 (1s) -hydroxyalkyl-oxapenem-3-carboxylic acids and their use as betalactamase inhibitors
06/21/1993CA2085639A1 Lip treatment composition
06/21/1993CA2083762A1 Methods of making 4" derivatives of 9-deoxo-8a-aza-8a- alkyl-8a-homoerythromycin a
06/20/1993CA2058876A1 Cyclic hiv principal neutralizing determinant peptides
06/19/1993CA2085084A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope
06/17/1993DE4140463A1 2'-desoxy-isoguanosin, dessen isostere analoge sowie anwendung derselben 2'-deoxy-isoguanosine, the isosteric analog and application thereof
06/17/1993CA2084800A1 Hiv protease inhibitors with an internal lactam ring
06/16/1993EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
06/16/1993EP0546787A2 Expression of specific immunogens using viral antigens
06/16/1993EP0546529A1 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same
06/16/1993EP0546349A2 PRP overproducing haemophilus influenzae strain
06/16/1993EP0546213A1 Biologically active polypeptide and antibacterial agent
06/16/1993EP0546179A1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof
06/16/1993EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome
06/16/1993EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
06/16/1993EP0546115A1 Peptides containing amino-polyols as transition-state mimics
06/16/1993EP0546077A1 Cd18 peptide medicaments for the treatment of disease
06/16/1993EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK
06/16/1993EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
06/16/1993EP0545991A1 Peptides that block human immunodeficiency virus infections and methods of use thereof
06/16/1993EP0531413A4 An antiviral composition
06/16/1993EP0332679B1 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
06/16/1993EP0290558B1 Antifolate agents
06/16/1993CN1073177A New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and their use as medicaments
06/16/1993CN1073161A Endothelin receptor antagonists
06/16/1993CN1021228C Improved vancomycin precipitation process
06/16/1993CN1021226C Preparation for acyl derivatives
06/16/1993CN1021225C Hydrate of penicillin derivative and process for preparing same
06/15/1993US5220059 An N-amino-, hydroxy or thiocarbonyl or thiocarbonyl, N-hydroxyaminoalkylene derivative
06/15/1993US5219990 Papillomavirus e2 trans-activation repressors
06/15/1993US5219859 Indole derivatives, preparation processes and medicinal products containing them
06/15/1993US5219848 Cephem compounds
06/15/1993US5219736 Process for producing 3-deacylated derivative of 16-membered macrolide antibiotic
06/15/1993US5219577 Biologically active composition having a nanocrystalline core
06/15/1993CA1319143C Antiviral compounds
06/14/1993CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
06/13/1993WO1993012128A1 DERIVATIVES OF 9-(β-D-XYLOFURANNOSYL)ADENINE AND OF 1-(β-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS
06/13/1993CA2103884A1 9-(b-d-xylofuranosyl)adenine and 1-(b-d-xylofuranosyl)cytosine derivatives, and preparation and therapeutic application thereof
06/13/1993CA2085137A1 New cephalosporins comprising a 7-substituted benzyloxyimino group, process of preparation thereof, their application as medication
06/12/1993CA2084180A1 Expression of specific immunogens using viral antigens
06/10/1993WO1993011140A1 Antiviral compositions and method for their use
06/10/1993WO1993011131A1 Cephalosporin compounds
06/10/1993WO1993011130A1 Rapamycin derivative and its medicinal use
06/10/1993WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments
06/10/1993WO1993010847A1 Method of reducing medical device related infections
06/10/1993WO1993010816A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
06/10/1993WO1993010799A1 Method of treating viral infections
06/10/1993WO1993010786A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin
06/10/1993WO1993010785A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
06/10/1993CA2125167A1 Method of reducing medical device related infections
06/10/1993CA2124691A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
06/10/1993CA2124444A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin
06/10/1993CA2124443A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
06/10/1993CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments
06/10/1993CA2084746A1 Prp overproducing haemophilus influenzae strain
06/10/1993CA2084334A1 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same
06/09/1993EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants
06/09/1993EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells
06/09/1993EP0544907A1 Antibacterial penem esters derivatives
06/09/1993EP0544906A1 Penem compounds
06/09/1993EP0544905A1 Antibacterial penem compounds
06/09/1993EP0544878A1 Asialoglycoprotein-conjugated medicinal agent
06/09/1993EP0544860A1 Novel biologically active peptide compositions and uses therefor
06/09/1993EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
06/09/1993EP0544705A1 Derivatives of mupirocin
06/09/1993EP0544668A1 -6-fluoro-9-(2,3-dideoxy-b-d-glycero-pentofuranosyl)-9h-purines and their use asantiviral agents
06/09/1993EP0531452A4 Synthesis of glycerol di- and triphosphate derivatives
06/09/1993EP0478708A4 Formation of triple helix complexes of double stranded dna using nucleoside oligomers
06/09/1993EP0358657B1 Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides)
06/09/1993CN1072843A Gel-type cosmetic composite
06/08/1993US5218130 4-substituted anthracyclinones and their preparation
06/08/1993US5218106 From 2'-doexy-2'-fluoronucleosides; viricides
06/08/1993US5217984 Viricides, human t-cell leukemia-lymphoma virus
06/08/1993US5217972 Quinolonecarboxylic acid derivatives and their use as antiviral agents
06/08/1993US5217960 Bactericides
06/08/1993US5217889 Randomly fragmenting DNA homologous to gene to be supressed, transferring fragments to expression vectors, introducing supressor library into living cells, isolating modified cells and obtaining supressor element from cells
06/08/1993CA1318850C Pharmaceutical products
06/02/1993EP0544321A1 Use of substituted cinnamic acid polymers to treat AIDS
06/02/1993EP0544307A1 Alkylaminoakylpyrrolidinylthiocarbapenem derivatives
06/02/1993EP0544171A1 Use of 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes for the preparation of antiretroviral agents.
06/02/1993EP0544169A1 6-thiono-5,6-dihydro-dibenz[b,e]azepin-11-ono-oximes and their use as retroviral agents
06/02/1993EP0544168A1 Aminoalkyl substituted 5,6-dihydro-dibenzo(b,e)azepin-6,11-dion-11-oximes
06/02/1993EP0544166A2 Cephalosporinderivatives
1 ... 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 ... 1798